NIH-funded research R03 grant

How glucose use by bacteria affects lung immunity in children

Official title: Host immunity in the lung is determined by the enhanced utilization of glucose by multi-drug resistant Klebsiella pneumoniae

Funded at Columbia University Health Sciences · NIH-11001928 · Data updated 2026-11-12

This study is looking at how tough-to-treat lung infections from a bacteria called Klebsiella pneumoniae affect the lung health of children who need ventilators, to better understand how these infections can make it harder for their lungs to work properly.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2025
Funding year2025
Award (this year)$123,375
NIH project number5R03HL171434-02
Project IDNIH-11001928 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children under 11 years old who are dependent on ventilators and at risk of infections from multi-drug resistant bacteria.

Less likely to help

Patients who are not dependent on ventilators or do not have infections caused by multi-drug resistant Klebsiella pneumoniae may not benefit from this research.

What this research studies

This research investigates how multi-drug resistant Klebsiella pneumoniae infections impact lung health in children who rely on ventilators. It focuses on understanding the relationship between bacterial glucose utilization and the inflammatory response in the lungs. By examining how these bacteria alter the metabolic environment, the study aims to uncover mechanisms that lead to persistent infections and impaired lung function. The research employs a combination of laboratory experiments and clinical observations to explore these interactions.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for lung infections in vulnerable children, potentially reducing the risk of acute deterioration and death.

How similar studies have gone: Previous studies have shown that understanding bacterial metabolism can lead to significant insights into infection management, suggesting potential for success in this novel approach.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Ahn, Danielle — Columbia University Health Sciences
  • Study coordinator: Ahn, Danielle

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.